Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1982-10-04
1988-11-15
Marantz, Sidney
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
435 68, 43524027, 435948, 436548, 530387, 935104, 935105, 935110, A61K 3900, G01N 33577
Patent
active
047849517
ABSTRACT:
Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 95% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF.sub.1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
REFERENCES:
Reinherz et al., J. Immunol., vol. 123, 1979, pp. 1312-1317.
Goldstein Gideon
Kung Patrick C.
Dellenbaugh Geoffrey G.
Marantz Sidney
Ortho Pharmaceutical Corporation
LandOfFree
Hybrid cell line for producing monoclonal antibody to antigen on does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid cell line for producing monoclonal antibody to antigen on, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid cell line for producing monoclonal antibody to antigen on will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1103400